KRISTIN JOHNSON: Open Payments
NPI 1588980460 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 28 payments from 9 companies in 2025. Trend: 2023 $1,285 · 2024 $1,418 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $233 |
| ABBVIE INC. | 6 | $142 |
| Lilly USA, LLC | 4 | $71 |
| Novo Nordisk Inc | 3 | $56 |
| Boston Scientific Corporation | 2 | $55 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
| MERZ NORTH AMERICA, INC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: FARXIGA, VRAYLAR, AIRSUPRA, WATCHMAN Access System, MOUNJARO, Wegovy, JARDIANCE, BREZTRI.
Industry payments across AL — which companies pay providers there.
